Developing Prediction Models for COVID-19 Outcomes: A Valuable Tool for Resource-Limited Hospitals.

ANC CRP risk profiling unfavourable outcome

Journal

International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487

Informations de publication

Date de publication:
2023
Historique:
received: 07 05 2023
accepted: 08 07 2023
medline: 25 7 2023
pubmed: 25 7 2023
entrez: 25 7 2023
Statut: epublish

Résumé

Coronavirus disease is a global pandemic with millions of confirmed cases and hundreds of thousands of deaths worldwide that continues to create a significant burden on the healthcare systems. The aim of this study was to determine the patient clinical and paraclinical profiles that associate with COVID-19 unfavourable outcome and generate a prediction model that could separate between high-risk and low-risk groups. The present study is a multivariate observational retrospective study. A total of 483 patients, residents of the municipality of Timișoara, the biggest city in the Western Region of Romania, were included in the study group that was further divided into 3 sub-groups in accordance with the disease severity form. Increased age (cOR=1.09, 95% CI: 1.06-1.11, p<0.001), cardiovascular diseases (cOR=3.37, 95% CI: 1.96-6.08, p<0.001), renal disease (cOR=4.26, 95% CI: 2.13-8.52, p<0.001), and neurological disorder (cOR=5.46, 95% CI: 2.71-11.01, p<0.001) were all independently significantly correlated with an unfavourable outcome in the study group. The severe form increases the risk of an unfavourable outcome 19.59 times (95% CI: 11.57-34.10, p<0.001), while older age remains an independent risk factor even when disease severity is included in the statistical model. An unfavourable outcome was positively associated with increased values for the following paraclinical parameters: white blood count (WBC; cOR=1.10, 95% CI: 1.05-1.15, p<0.001), absolute neutrophil count (ANC; cOR=1.15, 95% CI: 1.09-1.21, p<0.001) and C-reactive protein (CRP; cOR=1.007, 95% CI: 1.004-1.009, p<0.001). The best prediction model including age, ANC and CRP achieved a receiver operating characteristic (ROC) curve with the area under the curve (AUC) = 0.845 (95% CI: 0.813-0.877, p<0.001); cut-off value = 0.12; sensitivity = 72.3%; specificity = 83.9%. This model and risk profiling may contribute to a more precise allocation of limited healthcare resources in a clinical setup and can guide the development of strategies for disease management.

Identifiants

pubmed: 37489130
doi: 10.2147/IJGM.S419206
pii: 419206
pmc: PMC10363379
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3053-3065

Informations de copyright

© 2023 Popescu et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J Clin Med. 2022 Nov 16;11(22):
pubmed: 36431254
Front Immunol. 2022 Nov 14;13:1040024
pubmed: 36451818
Turk Pediatri Ars. 2020 Dec 16;55(4):335-336
pubmed: 33414649
J Osteopath Med. 2021 Sep 30;121(12):869-873
pubmed: 34592071
Front Immunol. 2022 Jun 01;13:864387
pubmed: 35720378
Clin Chim Acta. 2020 Oct;509:235-243
pubmed: 32533986
Acad Emerg Med. 2022 Feb;29(2):206-216
pubmed: 35064988
Allergy. 2021 Feb;76(2):428-455
pubmed: 33185910
BMJ Glob Health. 2021 Dec;6(12):
pubmed: 34916273
QJM. 2020 Dec 1;113(12):876-882
pubmed: 32790836
BMC Infect Dis. 2021 Jun 14;21(1):574
pubmed: 34126954
Invest Radiol. 2020 Jun;55(6):327-331
pubmed: 32118615
PLoS One. 2020 Nov 5;15(11):e0241824
pubmed: 33152008
J Bras Nefrol. 2021 Jul-Sep;43(3):383-399
pubmed: 33836039
Acad Emerg Med. 2020 Aug;27(8):653-670
pubmed: 32542934
Med. 2021 Apr 09;2(4):435-447.e4
pubmed: 33521746
Trop Dis Travel Med Vaccines. 2020 Aug 28;6:16
pubmed: 32868984
Diagnostics (Basel). 2021 Mar 26;11(4):
pubmed: 33810534
Front Neurol. 2020 Jul 07;11:781
pubmed: 32733373
J Glob Health. 2020 Dec;10(2):020510
pubmed: 33110593
Emerg Infect Dis. 2020 Aug;26(8):1839-1841
pubmed: 32384045
Int J Clin Pract. 2021 Oct;75(10):e14571
pubmed: 34170611
BMJ. 2020 Sep 9;370:m3339
pubmed: 32907855
Clin J Am Soc Nephrol. 2021 May 8;16(5):785-786
pubmed: 33558255
Rev Med Virol. 2021 Nov;31(6):e2221
pubmed: 34773448

Auteurs

Irina-Maria Popescu (IM)

Department of Infectious Diseases, Discipline of Epidemiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Madalin-Marius Margan (MM)

Department of Functional Sciences, Discipline of Public Health, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Mariana Anghel (M)

Department of Infectious Diseases, Discipline of Epidemiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Alexandra Mocanu (A)

Department of Infectious Diseases, Discipline of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Sorina Maria Denisa Laitin (SMD)

Department of Infectious Diseases, Discipline of Epidemiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Roxana Margan (R)

Department of Functional Sciences, Discipline of Physiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Ionut Dragos Capraru (ID)

Department of Infectious Diseases, Discipline of Epidemiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Alexandra-Andreea Tene (AA)

Regional Center of Public Health Timisoara, Timisoara, Romania.

Emanuela-Georgiana Gal-Nadasan (EG)

Department of Balneology, Medical Rehabilitation and Rheumatology, Discipline of Medical Rehabilitation, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Daniela Cirnatu (D)

Regional Center of Public Health Timisoara, Timisoara, Romania.
Department of Medicine, "Vasile Goldis" Western University, Faculty of Medicine, Arad, Romania.

Gratiana Nicoleta Chicin (GN)

Regional Center of Public Health Timisoara, Timisoara, Romania.
Department of Epidemiology, Infectious Diseases and Preventive Medicine, "Vasile Goldis" Western University, Faculty of Medicine, Arad, Romania.

Cristian Oancea (C)

Center for Research and Innovation in Precision Medicine of Respiratory Disease, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Andrei Anghel (A)

Department of Biochemistry and Pharmacology, Discipline of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Classifications MeSH